1. Home
  2. ETON vs CPZ Comparison

ETON vs CPZ Comparison

Compare ETON & CPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$18.99

Market Cap

411.9M

Sector

Health Care

ML Signal

HOLD

Logo Calamos Long/Short Equity & Dynamic Income Trust

CPZ

Calamos Long/Short Equity & Dynamic Income Trust

HOLD

Current Price

$14.32

Market Cap

297.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
CPZ
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
411.9M
297.4M
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
ETON
CPZ
Price
$18.99
$14.32
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$31.00
N/A
AVG Volume (30 Days)
282.3K
73.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,011,000.00
N/A
Revenue This Year
$107.23
N/A
Revenue Next Year
$29.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
23.29
N/A
52 Week Low
$11.09
$14.24
52 Week High
$23.00
$16.82

Technical Indicators

Market Signals
Indicator
ETON
CPZ
Relative Strength Index (RSI) 66.22 30.58
Support Level $16.09 N/A
Resistance Level $20.01 $15.13
Average True Range (ATR) 0.92 0.21
MACD 0.13 -0.05
Stochastic Oscillator 80.23 0.00

Price Performance

Historical Comparison
ETON
CPZ

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About CPZ Calamos Long/Short Equity & Dynamic Income Trust

Calamos L/S Equity & Dynamic Inc Trust is a trust company that seeks to provide current income and risk-managed capital appreciation, with an investment objective to deliver total return through a combination of capital appreciation and current income. The Fund invests in securities across sectors such as Industrials, Healthcare, Financials, Consumer Discretionary, and others, and holds securities with a broad range of maturities, with the average term to maturity typically ranging from two to ten years. Managed assets represent the Fund's total assets, including any assets attributable to leverage that may be outstanding, minus total liabilities other than debt representing financial leverage.

Share on Social Networks: